Gilead Sciences Market Cap

Gilead Sciences has a market cap or net worth of $208.48 billion as of November 13, 2026. It is the 82nd most valuable company in the world and the 53rd biggest in the United States. Its market cap has increased by 36.17% in one year.

Market Cap

208.48B

Enterprise Value

226.76B

1-Year Change

36.17%

Global Rank

#82

Country Rank

#53 United States

ChartMarket Cap Chart

Chart

Since December 1, 1998, Gilead Sciences's market cap has increased from $973.10M to $208.48B, an increase of 21,323.91%. That is a compound annual growth rate of 21.15%.

Market Cap History

Date	Market Cap	% Change
Nov 13, 2026	208.48B	36.90%
Dec 31, 2025	152.28B	32.28%
Dec 31, 2024	115.12B	14.04%
Dec 29, 2023	100.94B	-6.25%
Dec 30, 2022	107.68B	18.22%
Dec 31, 2021	91.08B	24.72%
Dec 31, 2020	73.03B	-11.17%
Dec 31, 2019	82.21B	1.60%
Dec 31, 2018	80.92B	-13.53%
Dec 29, 2017	93.58B	-0.81%
Dec 30, 2016	94.34B	-35.31%
Dec 31, 2015	145.83B	2.55%
Dec 31, 2014	142.21B	23.49%
Dec 31, 2013	115.15B	106.93%
Dec 31, 2012	55.65B	81.01%
Dec 30, 2011	30.74B	4.49%
Dec 31, 2010	29.42B	-24.44%
Dec 31, 2009	38.94B	-16.37%
Dec 31, 2008	46.56B	8.73%
Dec 31, 2007	42.82B	43.43%
Dec 29, 2006	29.86B	24.03%
Dec 30, 2005	24.07B	58.92%
Dec 31, 2004	15.15B	28.36%
Dec 31, 2003	11.80B	76.49%
Dec 31, 2002	6.69B	6.07%

View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Related Stocks

Company	Market Cap
Johnson & Johnson	687.89B
AbbVie	521.50B
Merck & Co.	364.26B
Novartis AG	302.07B
AstraZeneca	286.87B
Amgen	251.89B
Novo Nordisk	181.25B
Pfizer	164.67B

Market Cap Rankings